[III. Molecular targeting therapy for glioma-bevacizumab and cilengitide].

Kazuhiko Kurozumi; Manabu Onishi; Tomotsugu Ichikawa; Kentaro Fujii; Jyouji Ishida; Yosuke Shimazu; Isao Date

[III. Molecular targeting therapy for glioma-bevacizumab and cilengitide].

Kazuhiko Kurozumi, Manabu Onishi, Tomotsugu Ichikawa, Kentaro Fujii, Jyouji Ishida, Yosuke Shimazu, Isao Date

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	718-722
Number of pages	5
Journal	Gan to kagaku ryoho. Cancer & chemotherapy
Volume	40
Issue number	6
Publication status	Published - Jun 1 2013
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{1ad210ca88d4403383a522d2c36e79ec,

title = "[III. Molecular targeting therapy for glioma-bevacizumab and cilengitide].",

author = "Kazuhiko Kurozumi and Manabu Onishi and Tomotsugu Ichikawa and Kentaro Fujii and Jyouji Ishida and Yosuke Shimazu and Isao Date",

year = "2013",

month = jun,

day = "1",

language = "English",

volume = "40",

pages = "718--722",

journal = "Japanese Journal of Cancer and Chemotherapy",

issn = "0385-0684",

publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",

number = "6",

}

TY - JOUR

T1 - [III. Molecular targeting therapy for glioma-bevacizumab and cilengitide].

AU - Kurozumi, Kazuhiko

AU - Onishi, Manabu

AU - Ichikawa, Tomotsugu

AU - Fujii, Kentaro

AU - Ishida, Jyouji

AU - Shimazu, Yosuke

AU - Date, Isao

PY - 2013/6/1

Y1 - 2013/6/1

UR - http://www.scopus.com/inward/record.url?scp=84882247553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882247553&partnerID=8YFLogxK

M3 - Article

C2 - 23957062

AN - SCOPUS:84882247553

SN - 0385-0684

VL - 40

SP - 718

EP - 722

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

IS - 6

ER -

[III. Molecular targeting therapy for glioma-bevacizumab and cilengitide].

ASJC Scopus subject areas

UN SDGs

Other files and links

Cite this